Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction

Cardiology

Volumn 90, Issue 2, 1998, Pages 127-130

  Serebruany, Victor L ^a,c   Gurbel, Paul A ^a   Murugesan, Selva R ^a   Lowry, David R ^a   Sturm, Ekkehard ^b   Svetlov, Stanislav I ^b  

^a SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

Acute myocardial infarction, human; Platelet activating factor; Platelet activating factor acetylhydrolase

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY;

EID: 0031763395     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006831     Document Type: Article

References (27)

1. Nidorf SM, Sturm M, Strophair J, Kendrew PJ, Taylor RR: Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina. Cardiovasc Res 1989;23:273-278.
2. Tselepis AD, Tsoukatos D, Droudes C, Donas A, Evangelou A: Platelet response to the aggregatory effects of platelet activating factor (PAF) ex vivo in patients with acute myocardial infarction. Eur J Clin Invest 1991;21:490-496.
3. Chakrabarty S, Thomas P, Sheridan DJ: Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischemia. Eur Heart J 1991;12:583-589.
4. Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM: Mammalian platelet-activating factor acetylhydrolases. Biochim Biophys Acta 1996;1301:161-173.
5. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA: Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 1995;95:774-782.
6. Tew DG, Southan C, Rice SQ, Lawrence MP, Li H, Boyd HF, Moores K, Gloger IS, Macphee CH: Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler Thromb Vasc Biol 1996;16:591-599.
7. The GUSTO III Investigators: A comparison of reteplase and alteplase for acute myocardial infarction. N Engl J Med 1997;337:1118-1123.
8. Stafforini DM, Prescott SM, McIntyre TM: Platelet-activating factor acetylhydrolase in human erythrocytes. Methods Enzymol 1991;197:411-425.
9. Hattori M, Arai H, Inoue K: Purification and characterization of bovine brain platelet-activating factor acetylhydrolase. J Biol Chem 1993;268:18748-18753.
10. Kleiman NS, Ohman EM, Califf RM, George BS, Kereiakes D, Aguirre FV, Weisman H, Schaible T, Topol EJ: Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study. J Am Coll Cardiol 1993;22:381-389.
11. Weyrich AS, Ma XL, Lefer DJ, Albertine KH, Lefer AM: In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-2629.
12. Elstad MR, Stafforini DM, McIntyre TM, Prescott SM, Zimmerman GA: Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J Biol Chem 1989;264:8467-8470.
13. Strahan ME, Graham RM, Eccleston DS, Sturm MJ, Taylor RR: Neutrophil platelet-activating factor production and acetyltransferase activity in clinical acute myocardial infarction. Clin Exp Pharmacol Physiol 1995;22:102-106.
14. Montrucchio G, Lupia E, De Martino A, Silvestro L, Savu SR, Cacace G, De Filippi PG, Emanuelli G, Camussi G: Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin. Circulation 1996;93:2152-2160.
15. Bussolino F, Camussi G: Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur J Biochem 1995;229:327-337.
16. Ansley DM, Qayumi AK, Duncan S, Merrick PM, Klein R: Platelet activating factor and thromboxane B2 production after cardiopulmonary bypass. J Invest Surg 1997;10:87-95.
17. Graham RM, Strahan ME, Norman KW, Watkins DN, Sturm MJ, Taylor RR: Platelet and plasma platelet-activating factor in sepsis and myocardial infarction. J Lipid Mediat Cell Signal 1994;9:167-182.
18. Siminiak T, Egdell RM, O'Gorman DJ, Dye JF, Sheridan DJ: Plasma-mediated neutrophil activation during acute myocardial infarction: Role of platelet-activating factor. Clin Sci 1995;89:171-176.
19. Montrucchio G, Bergerone S, Bussolino F, Alloatti G, Silvestro L, Lupia E, Cravetto A, Di Leo M, Emmanuelli G, Camussi G: Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Circulation 1993;88:1476-1483.
20. Stephens CJ, Graham RM, Sturm MJ, Richardson M, Taylor RR: Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction. Coron Artery Dis 1993;4:187-193.
21. Pennewitz A, Finkelberg L, Krause S, Losche W: Platelets inhibit the activity of platelet-activating factor acetylhydrolase in monocyte-derived macrophages. Thromb Res 1997;86:427-430.
22. Serebruany VL, Gurbel PA, Shustov AR, Dalesandro M, Gumbs SI, Grabletz BS, Bahr RD, Ohman EM, Topol EJ, for the GUSTO-III Investigators: Depressed platelet status in a patient with hemorrhagic stroke following thrombolysis for acute myocardial infarction. Stroke 1998;29:235-238.
23. Serebruany VL, Gurbel PA, Shustov AR, Ohman EM, Topol EJ: Heterogeneity of platelet aggregation and major surface receptor expression in patients presenting with acute myocardial infarction. Am Heart J, in press.
24. Tsukioka K, Matsuzaki M, Nakamata M, Kayahara H, Nakagawa T: Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. J Invest Allergol Clin Immunol 1996;6:22-29.
25. Patrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC: Reduced PAF-acetylhydrolase activity is associated with postinjury multiple organ failure. Shock 1997;7:170-174.
26. Yamada Y, Yokota M: Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281 → Arg mutation. Biochem Biophys Res Commun 1997;236:772-775.
27. Hiramoto M, Yoshida H, Imaizumi T, Yoshimuzi N, Satoh K: A mutation in plasma platelet activating factor acetylhydrolase (Val279→Phe) is a genetic risk factor for stroke. Stroke 1997;28:2417-2420.